OLA
AGN

Oliver Luxxe Assets’s Allergan plc AGN Stock Holding History

Oliver Luxxe Assets’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,550
Closed -$3.05M – 85
2017
Q2 		$3.05M Buy
12,550
+247
+2% +$58K 1.98% 17
2017
Q1 		$2.94M Buy
+12,303
New +$2.87M 1.96% 18
2016
Q2 		– Sell
-1,163
Closed -$312K – 90
2016
Q1 		$312K Hold
1,163
– – 0.32% 63
2015
Q4 		$329K Buy
+1,163
New +$346K 0.29% 85

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Oliver Luxxe Assets's AGN Position: Q3 2017 in Review

Oliver Luxxe Assets sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 12,550 shares — an estimated $3.05M sold.

Oliver Luxxe Assets first reported a position in AGN in Q4 2015 and held it in 4 quarters. The position peaked at $3.05M in Q2 2017. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Oliver Luxxe Assets reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Oliver Luxxe Assets sold 12,550 Allergan plc shares in Q3 2017, an estimated $3.05M.
  • Oliver Luxxe Assets first reported a position in Allergan plc in Q4 2015 and held it in 4 quarters.
  • Oliver Luxxe Assets's Allergan plc position peaked at $3.05M in Q2 2017.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Oliver Luxxe Assets's 13F filing for Q3 2017, filed 23 Oct 2017.